Carbetocin vs. oxytocin at elective caesarean delivery: challenges and complexities in performing and interpreting a non-inferiority trial
- PMID: 37337425
- DOI: 10.1111/anae.16066
Carbetocin vs. oxytocin at elective caesarean delivery: challenges and complexities in performing and interpreting a non-inferiority trial
Comment in
-
Carbetocin vs. oxytocin at elective caesarean delivery: a reply.Anaesthesia. 2023 Oct;78(10):1307-1308. doi: 10.1111/anae.16094. Epub 2023 Jul 13. Anaesthesia. 2023. PMID: 37443428 No abstract available.
Comment on
-
Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens.Anaesthesia. 2022 Aug;77(8):892-900. doi: 10.1111/anae.15714. Epub 2022 Mar 28. Anaesthesia. 2022. PMID: 35343585 Clinical Trial.
References
-
- McDonagh F, Carvalho JCA, Abdulla S, et al. Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens. Anaesthesia 2022; 77: 892-900.
-
- Walker J. Non-inferiority statistics and equivalence studies. British Journal of Anaesthesia Education 2019; 19: 267-71.
-
- Cuzick J, Sasieni P. Interpreting the results of noninferiority trials-a review. British Journal of Cancer 2022; 127: 1755-9.
-
- Rosseland LA, Hauge TH, Grindheim G, Stubhaug A, Langesaeter E. Changes in blood pressure and cardiac output during cesarean delivery: the effects of oxytocin and carbetocin compared with placebo. Anesthesiology 2013; 119: 541-51.
-
- World Health Organization. WHO recommendations: Uterotonics for the prevention of postpartum haemorrhage. Web annex 2: Carbetocin versus placebo or no treatment. 2018. https://www.ncbi.nlm.nih.gov/books/NBK535977/pdf/Bookshelf_NBK535977.pdf (accessed 17/05/2023).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources